CN1389565A

CN1389565A - Culture process of human nerve stem cell

Info

Publication number: CN1389565A
Application number: CN02134313A
Authority: CN
Inventors: 徐如祥; 姜晓丹
Original assignee: Individual
Current assignee: Individual
Priority date: 2002-07-08
Filing date: 2002-07-08
Publication date: 2003-01-08
Anticipated expiration: 2022-07-08
Also published as: CN1171991C

Abstract

The invention discloses a cultivated method of nervous stem cells, it includes following steps:1, Nervous stem cells substrate of human being is made up of base cultivate liquid which is compounded by mixing DMEM and F12 by rate of 1:1, and insulin, muriatic acid butyl amic, selenium natrium, ydrogen cortisone, L-glutamic acyl amic, man-turn iron albumen, flavone; 2, Noumenon serum of patient themselves is gathered immediately; 3. Noumenon serum of patient themselves is put into compounded Nervous stem cells substrate of human being, them, it is incubated by adding 3-7% CO2 warmer under conditino of 35C-38C. The method of the invention is simple, and invention has better repetition and its operation is simple and convenient; it plays an inestimable part in researching, teaching, clinic application, etc all of which relate to nervous stem cell and its application.

Description

The cultural method of human nerve stem cell

Technical field

The present invention relates to a kind of cell culture processes, especially relate to a kind of cultural method of human nerve stem cell.

Background technology

Neural stem cell research has been the domestic and international recent studies on problem since 1998.Neural stem cell is the multipotential cell of central nervous system, it is the common precursor cell of three kinds of main cells (neurone, astroglia cell and oligodendrocyte) in the brain, have following characteristic: (1) is in undifferentiated state, the specificity marker of no mature cell; (2) have multidirectional differentiation potential, promptly develop into the ability of dissimilar mature cells; (3) can self-replacation or renewal by asymmetric division, produce and own identical daughter cell, thereby keep stablizing of cell number.Source of neural stem cells mainly contains four aspects: embryonic stem cell or embryo's nervous tissue, neural crest cell, cerebral tissue, bone marrow matrix.Just because neural stem cell is to have the neurone of being divided into, astroglia cell, the ability of oligodendrocyte, can self and be enough to provide the cell of a large amount of brain tissue cells, therefore culture of neural stem cells neural is intended to regulation and control in special substratum are divided into the neural stem cell with propagation and differentiation potential as certain histocyte in seed cell source (as patient's autologous bone marrow mesenchymal cell etc.), so that carrying out the patient feeds back from body, the infringement of treatment central nervous system function is for experiment basis is established in the clinical neural stem cells transplantation treatment that further is applied to patient's relative disease.

For general embryonic stem cell, under control environment, can become various histocyte by differential growth, the available embryonic stem cell of old friends cultivates various new organizations even organ is transplanted.And for neural stem cell, principal focal point is successfully to cultivate, to obtain from different approach the neural precursor of sufficient amount, for transplantation treatment or carry out transgeneic procedure and attack growth of tumor, observe the neural activity of some synthetic/natural compounds etc.Such as, if can from the patient from body take out myeloid tissue as the seed cell of neural stem cell, be induced to differentiate into neural stem cell under certain condition and then feed back in the patient in the body body, and under the local microenvironment effect, produce dopaminergic nerve cell, just can be used for treating its parkinsonism.And make this technology key in application prerequisite, be to make seed cells such as bone marrow in specific environment, cultivate into required neural stem cell.And the existing synthetic cell substratum that adopts mainly to act on be the microenvironment that general existence growth is provided for the different sorts histocyte, as Eagle, DMEM, F12, RPMI1640, CMRL1066, L15,199, MB752/1 etc., it mainly contains composition is amino acid, VITAMIN, inorganic salt, carbohydrate etc., and the method for utilizing these synthetic medium culturing cells is the seed cell (as myeloid tissue cell etc.) of different sources can not be cultivated into required neural stem cell.

Summary of the invention

The object of the present invention is to provide a kind ofly can make the directed cultural method that is divided into human nerve stem cell of growing of different sources seed cell such as human marrow tissue, can be at any time provide the relevant neural stem cell that needs for medical research teaching and clinical application like clockwork.

For achieving the above object, the present invention includes following steps:

1, preparation human nerve stem cell substratum, this culture medium preparation step is: a, get DMEM and F12 by the basic culture solution that mixes at 1: 1, adding pure water to concentration is 10～25g/L, and abundant stirring and dissolving, makes the general basic culture solution of cell; B, get Regular Insulin (Insulin), L-glutaminate (L-Glutamine), hydrochloric acid butanediamine (Putrescine), sodium selenide (Sodium Selenide), human transferrin (Transferrin), hydrocortisone (Hydrocortisone), Progesterone (Progesterone) again and add successively in the basic culture solution, stir; C, to transfer pH with 1～10 centinormal 1 sodium hydroxide be 7.4～8.0; D, the sterilization of laminar flow cell culture chamber suction filtration, 4 ℃ store for future use.

2, instantaneous acquiring patient autoserum, acquisition step is: a, preparation glass centrifuge tube, disposable sterilized injector, alcohol swab; B, routine disinfection, forearm vein are got blood, do not add any antithrombotics; C, venous blood is placed aseptic glass centrifuge tube, under room temperature or the 4 ℃ of conditions, centrifugal 1500～1800rmp, 10 minutes, can obtain patient's autoserum, collect serum;

3, get the human nerve stem cell substratum that step 1 makes, get step 2 instantaneous acquiring patient autoserum and add in the substratum, the content of serum is 5～20% of substratum; The substratum that adds serum is placed incubator, 35 ℃～38 ℃, add 3～7% CO ₂Incubation 11～21 days.

The weight proportion of each component that substratum comprises is described in the step 1 of the present invention:

DMEM and F12 are by the basic culture solution 10000～25000 that mixes at 1: 1

Regular Insulin (Insulin) 4.5～12.5

L-glutaminate (L-Glutamine) 3.5～12.5

Hydrochloric acid butanediamine (Putrescine) 9.2～35.6

Sodium selenide (Sodium Selenide) 0.01～0.51

Human transferrin (Transferrin) 50.0～150.0

Hydrocortisone (Hydrocortisone) 5.0～35.0

Progesterone (Progesterone) 0.01～0.55

The present invention compared with prior art has following advantage: 1, because the basic microenvironment that the basic culture solution that DMEM among the present invention and F12 mix grows as general seed cell; Regular Insulin can pass through to promote cellular uptake glucose and amino acid, thereby promotes the cell proliferation division, particularly promotes the neural stem cell growth; L-glutaminate can promote nucleic acid during the neural stem cell development growth, proteinic synthetic; The hydrochloric acid butanediamine can stimulate, induced nerve stem cells propagation; Sodium selenide participates in, promotes the neural stem cell metabolism; Human transferrin can be in conjunction with iron ion, reduces its toxicity and is utilized by cell, makes neural stem cell quantity increase, be reduced to the fibrocyte number simultaneously; Hydrocortisone promotes neural stem cell to grow; Progesterone promotes the neural stem cell growth.Identify the distinctive high-affinity antigen NESTIN of expression with the neural stem cell that the inventive method is cultivated through immunocytochemistry; Express the antigenic neural stem cell of NESTIN and can further be divided into neurone, neurogliocyte, proof the inventive method can induce the various sources histocyte that comprises the myeloid tissue seed cell to be divided into neural stem cell effectively, and its induction time is 11～21 days; 2, the neural stem cells transplantation that the inventive method is cultivated is around Spinal injury patient's focus, transplant that patient's clinical symptom has clear improvement after 3 months, show as recoveries in various degree such as motor function, consciousness function, metabolic function, the most desirable person can be by original long-term clinostatism to holding up object to stand; 3, keep the neural stem cell growth with patient's autoserum composition, effect is good, and the possibility that does not exist transplanted cells foreign sera protein immunization to repel; 4, the inventive method is simple, and is repeatable strong, easy to operation; Immeasurable effect be can play for the scientific research of relevant neural stem cell and application thereof, teaching, clinical application etc., huge social benefit and economic benefit also bred simultaneously.

Embodiment

Present embodiment may further comprise the steps:

1, preparation human nerve stem cell substratum, this culture medium preparation step is: a, get DMEM and F12 by the basic culture solution 12g that mixes at 1: 1, adding pure water to concentration is 12g/L, and abundant stirring and dissolving, makes the general basic culture solution of cell; B, get Regular Insulin (Insulin) 5mg, L-glutaminate (L-Glutamine) 3.9mg, hydrochloric acid butanediamine (Putrescine) 10mg, sodium selenide (Sodium Selenide) 0.03mg, human transferrin (Transferrin) 50mg again, hydrocortisone (Hydrocortisone) 10mg, Progesterone (Progesterone) 0.02mg add in the prepared basic culture solution of step 1 successively, stir, and be 1000 milliliters with the pure water constant volume, be orange little turbid state this moment; C, to transfer pH with 5 centinormal 1 sodium hydroxide be 7.8, and this moment, substratum was pink limpid state; D, laminar flow cell culture chamber suction filtration sterilization (the filtering membrane bore dia is 0.22 μ m specification), 4 ℃ store for future use.

2, instantaneous acquiring patient autoserum, acquisition step is: a, preparation 10ml specification glass centrifuge tube, disposable sterilized injector, alcohol swab; B, routine disinfection, forearm vein are got 10 milliliters of blood, do not add any antithrombotics; C, venous blood is placed aseptic glass centrifuge tube, under room temperature or the 4 ℃ of conditions, centrifugal 1500～1800rmp, 10 minutes, can obtain 3～6ml patient autoserum, collect serum;

3, get the human nerve stem cell substratum 10g that step 1 makes, get step 2 instantaneous acquiring patient autoserum 1g and add in the substratum; The substratum that adds serum is placed incubator, 37 ℃, add 5% CO ₂Incubation 15 days.

Claims

1, a kind of cultural method of human nerve stem cell is characterized in that may further comprise the steps:

(1) preparation human nerve stem cell substratum, this culture medium preparation step is: a, get DMEM and F12 by the basic culture solution that mixes at 1: 1, adding pure water to concentration is 10～25g/L, and abundant stirring and dissolving, makes the general basic culture solution of cell; B, get Regular Insulin (Insulin), L-glutaminate (L-Glutamine), hydrochloric acid butanediamine (Putrescine), sodium selenide (Sodium Selenide), human transferrin (Transferrin), hydrocortisone (Hydrocortisone), Progesterone (Progesterone) again and add successively in the basic culture solution, stir; C, to transfer pH with 1～10 centinormal 1 sodium hydroxide be 7.4～8.0; D, the sterilization of laminar flow cell culture chamber suction filtration, 4 ℃ store for future use.

(2) instantaneous acquiring patient autoserum, acquisition step is: a, preparation glass centrifuge tube, disposable sterilized injector, alcohol swab; B, routine disinfection, forearm vein are got blood, do not add any antithrombotics; C, venous blood is placed aseptic glass centrifuge tube, under room temperature or the 4 ℃ of conditions, centrifugal 1500～1800rmp, 10 minutes, can obtain patient's autoserum, collect serum;

(3) get the human nerve stem cell substratum that step 1 makes, get step 2 instantaneous acquiring patient autoserum and add in the substratum, the content of serum is 5～20% of substratum; The substratum that adds serum is placed incubator, 35 ℃～38 ℃, add 3～7% CO ₂Incubation 11～21 days.

2, the cultural method of a kind of human nerve stem cell according to claim 1 is characterized in that the weight proportion of each component that substratum comprises described in the step 1 is: